Patents by Inventor Feng-Di T. Lung

Feng-Di T. Lung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080031812
    Abstract: A compound of formula: in which (i) aa1 is Adi and aa4 is Glu or (ii) each of aa1 and aa4 is Adi, L is sulfur, sulfoxide, oxygen or methylene, which compound (and its conjugates) bind to an SH2 domain in a protein comprising an SH2 domain, is non-phosphorylated, is redox-stable in vivo, is characterized by an IC50 in vivo of less than about 4.0 ?M with respect to the SH2 domain in Grb2, and, upon binding to the SH2 domain of Grb2, has a turn conformation. A conjugate comprising a compound as described above and a carrier agent, a composition comprising (i) a compound or a conjugate as described above and (ii) a carrier, a method of inhibiting binding of an SH2 domain in a protein comprising an SH2 domain to a target protein in an animal, wherein the SH2 domain is contacted with a target protein-binding inhibiting effective amount of a compound or a conjugate as described above, and a method of synthesizing such conjugates.
    Type: Application
    Filed: August 14, 2007
    Publication date: February 7, 2008
    Applicants: GOVERNMENT OF THE USA, REPRESENTED BY THE SECRETARY, DEPA., GEORGETOWN UNIVERSITY
    Inventors: Peter Roller, Ya-Qiu Long, Feng-Di T. Lung, C. Richter King, Dajun Yang, Johannes Voigt
  • Patent number: 7259142
    Abstract: A compound of formula: in which (i) aa1 is Adi and aa4 is Glu or (ii) each of aa1 and aa4 is Adi, L is sulfur, sulfoxide, oxygen or methylene, which compound (and its conjugates) bind to an SH2 domain in a protein comprising an SH2 domain, is non-phosphorylated, is redox-stable in vivo, is characterized by an IC50 in vivo of less than about 4.0 ?M with respect to the SH2 domain in Grb2, and, upon binding to the SH2 domain of Grb2, has a turn conformation. A conjugate comprising a compound as described above and a carrier agent, a composition comprising (i) a compound or a conjugate as described above and (ii) a carrier, a method of inhibiting binding of an SH2 domain in a protein comprising an SH2 domain to a target protein in an animal, wherein the SH2 domain is contacted with a target protein-binding inhibiting effective amount of a compound or a conjugate as described above, and a method of synthesizing such conjugates.
    Type: Grant
    Filed: September 13, 2005
    Date of Patent: August 21, 2007
    Assignee: The United States of America, represented by the Secretary, Department of Health and Human Services
    Inventors: Peter P Roller, Ya-Qui Long, Feng-Di T. Lung, C. Richter King, Dajun Yang, Johannes H. Voigt
  • Patent number: 6951915
    Abstract: A compound of formula: in which L is sulfur, sulfoxide, oxygen or methylene, and a compound of formula: in which (i) aa1 is Adi and aa4 is Glu or (ii) each of aa1 and aa4 is Adi, L is sulfur, sulfoxide, oxygen or methylene, which compounds (and their conjugates) bind to an SH2 domain in a protein comprising an SH2 domain, are non-phosphorylated, are redox-stable in vivo, are characterized by an IC50 in vivo of less than about 4.0 ?M with respect to the SH2 domain in Grb2, and, upon binding to the SH2 domain of Grb2, have a turn conformation.
    Type: Grant
    Filed: November 30, 2001
    Date of Patent: October 4, 2005
    Assignees: The United States of America as represented by the Department of Health and Human Services, Georgetown University
    Inventors: Peter P. Roller, Ya-Qiu Long, Feng-Di T. Lung, C. Richter King, Dajun Yang
  • Publication number: 20030078368
    Abstract: A compound of formula: 1
    Type: Application
    Filed: November 30, 2001
    Publication date: April 24, 2003
    Applicant: The Govt. of the United States of America
    Inventors: Peter P. Roller, Ya-Qiu Long, Feng-Di T. Lung, C. Richter King, Dajun Yang